Elesclomol and Luminespib Modulate Redox-Related Gene Expression, c-MYC and Apoptosis in Triple-Negative MDA-MB-231 Breast Cancer Cells

Triple-negative breast cancer (TNBC) lacks targeted therapeutic options, and redox homeostasis and MYC-associated glutathione metabolism may represent a vulnerability. We evaluated the copper ionophore elesclomol and the HSP90 inhibitor luminespib, alone and combined, in MDA-MB-231 cells. Viability after treatment with elesclomol, luminespib, ganetespib or onalespib (0.05–0.2 µM) was measured via alamarBlue assay, and sensitivity was examined in the Genomics of Drug Sensitivity in Cancer (GDSC) dataset. Cells were then treated with elesclomol (0.05 µM), luminespib (0.1 µM) or both for apoptosis analysis (Annexin V-FITC/7-AAD), qPCR (c-MYC, GSS, CAT, SOD1, NOX1, NOS2, TGFB1) and multivariate, network and enrichment analyses. Elesclomol was the most potent compound, reducing viability to approximately 5% of control at 72 h versus 43% for luminespib. Quantification of Annexin V-positive cells across replicates showed an increase from 1.1% in the control group to 11.6% in the elesclomol group, 10.2% in luminespib and 13.2% in the combination groups, respectively (p < 0.0001). All treatments decreased c-MYC and increased GSS expression; elesclomol produced the largest increases in NOS2 and CAT, and the combination in NOX1. Principal component analysis separated the treatment groups (87.1% of variance on PC1 and PC2). Elesclomol had the most pronounced effects across assays. The observed decrease in c-MYC expression and increase in GSS expression suggest a potential association between MYC-related and glutathione-related pathways, warranting further mechanistic investigation.

Authors

Institutions

Publication Details

Journal
Antioxidants
Published
2026-11-18
DOI
https://doi.org/10.3390/antiox15111501
Primary Topic
Redox biology and oxidative stress
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Elesclomol and Luminespib Modulate Redox-Related Gene Expression, c-MYC and Apoptosis in Triple-Negative MDA-MB-231 Breast Cancer Cells

Sheikh F. Ahmad, Seema Zargar, Sameerah Yasain Shaheen, Salman Freeh Alamery et al.
Antioxidants
Redox biology and oxidative stress
article

Elesclomol and Luminespib Modulate Redox-Related Gene Expression, c-MYC and Apoptosis in Triple-Negative MDA-MB-231 Breast Cancer Cells

Sheikh F. Ahmad, Seema Zargar, Sameerah Yasain Shaheen, Salman Freeh Alamery, Mona Ahmed Elsafadi, Tanveer A. Wani, Sumaiya Tareen, Abdulaziz Mohammed Alamri, Mona Shujaa Alharbi, King Saud University
article en

Abstract

Triple-negative breast cancer (TNBC) lacks targeted therapeutic options, and redox homeostasis and MYC-associated glutathione metabolism may represent a vulnerability. We evaluated the copper ionophore elesclomol and the HSP90 inhibitor luminespib, alone and combined, in MDA-MB-231 cells. Viability after treatment with elesclomol, luminespib, ganetespib or onalespib (0.05–0.2 µM) was measured via alamarBlue assay, and sensitivity was examined in the Genomics of Drug Sensitivity in Cancer (GDSC) dataset. Cells were then treated with elesclomol (0.05 µM), luminespib (0.1 µM) or both for apoptosis analysis (Annexin V-FITC/7-AAD), qPCR (c-MYC, GSS, CAT, SOD1, NOX1, NOS2, TGFB1) and multivariate, network and enrichment analyses. Elesclomol was the most potent compound, reducing viability to approximately 5% of control at 72 h versus 43% for luminespib. Quantification of Annexin V-positive cells across replicates showed an increase from 1.1% in the control group to 11.6% in the elesclomol group, 10.2% in luminespib and 13.2% in the combination groups, respectively (p < 0.0001). All treatments decreased c-MYC and increased GSS expression; elesclomol produced the largest increases in NOS2 and CAT, and the combination in NOX1. Principal component analysis separated the treatment groups (87.1% of variance on PC1 and PC2). Elesclomol had the most pronounced effects across assays. The observed decrease in c-MYC expression and increase in GSS expression suggest a potential association between MYC-related and glutathione-related pathways, warranting further mechanistic investigation.

AntioxidantsVol. 15(11)
King Saud University (SA)
King Saud University
Good health and well-being
Redox biology and oxidative stress
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon